Most Read

There's new hope for those with severe MS

FDA approves a promising new drug for MS.

[DIGEST: New York Times, NBC]

Late last month, the Federal Drug Administration approved a new drug to treat multiple sclerosis. The drug, called ocrelizumab, is the first FDA-approved drug to treat primary progressive MS, a severe form of multiple sclerosis. It is also approved to help the more common form of the disease known as relapse-remitting.

Keep reading... Show less